Skip to main content

Rare Tumors: A Different Perspective on Oncology

  • Chapter
  • First Online:

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Compared to cancer in adults, childhood cancer is rare, accounting for significantly less than 1% of all cancer diagnoses. Since increasing age constitutes a significant risk factor for the development of cancer, it is supposed that the overall prevalence of cancer will continuously increase while the average life expectancy rises. In contrast, birthrates are declining in most western countries, thus leading to a further decline of the overall incidence rate of childhood cancer. Thus, the question arises, what will define a rare tumor in childhood and adolescence, if the overall numbers are generally low. Is a rare cancer defined only by incidence numbers, or do specific clinical, pathological, or biological characteristics define a tumor to be rare?

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Baranzelli MC, Flamant F et al (1993) Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the “Societe Francaise d’Oncologie Pediatrique” MGCT 1985–1989 study. Med Pediatr Oncol 21(6):395–401

    Article  PubMed  CAS  Google Scholar 

  • Brecht IB, Graf N et al (2009) Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klin Pädiatr 221(3):181–185

    Article  PubMed  CAS  Google Scholar 

  • Cerroni L, Barnhill R et al (2010) Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 34(3):314–326

    Article  PubMed  Google Scholar 

  • Cushing B, Giller R et al (2004) Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a Pediatric Intergroup Study – Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol 22(13):2691–2700

    Article  PubMed  CAS  Google Scholar 

  • Demetri GD, van Oosterom AT et al (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368(9544):1329–1338

    Article  PubMed  CAS  Google Scholar 

  • Ducharme EE, Silverberg NB (2009) Pediatric malignant melanoma: an update on epidemiology, detection, and prevention. Cutis 84(4):192–198

    PubMed  Google Scholar 

  • Durno C, Aronson M et al (2005) Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 54(8):1146–1150

    Article  PubMed  CAS  Google Scholar 

  • Erdman SH (2007) Pediatric adenomatous polyposis syndromes: an update. Curr Gastroenterol Rep 9(3):237–244

    Article  PubMed  Google Scholar 

  • Ferrari A, Sultan I (2010) When adult cancers occur in children. Expert Rev Anticancer Ther 10(11):1683–1685

    Article  PubMed  Google Scholar 

  • Ferrari A, Bono A et al (2005) Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 115(3):649–654

    Article  PubMed  Google Scholar 

  • Ferrari A, Bisogno G et al (2007) The challenge of very rare tumours in childhood: the Italian TREP project. Eur J Cancer 43(4):654–659

    Article  PubMed  Google Scholar 

  • Ferrari A, Rognone A et al (2008) Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer 50(3):588–593

    Article  PubMed  Google Scholar 

  • Ferrari A, Casanova M et al (2010) Peculiar features and tailored management of adult cancers occurring in pediatric age. Expert Rev Anticancer Ther 10(11):1837–1851

    Article  PubMed  Google Scholar 

  • Göbel U, Calaminus G et al (2002) Management of germ cell tumors in children: approaches to cure. Onkologie 25(1):14–22

    Article  PubMed  CAS  Google Scholar 

  • Half EE, Bresalier RS (2004) Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol 20(1):32–42

    Article  PubMed  Google Scholar 

  • Hill DA, Furman WL et al (2007) Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 25(36):5808–5814

    Article  PubMed  Google Scholar 

  • Hill DA, Ivanovich J et al (2009) DICER1 mutations in familial pleuropulmonary blastoma. Science 325(5943):965

    Article  PubMed  CAS  Google Scholar 

  • Janeway KA, Albritton KH et al (2009) Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer 52(7):767–771

    Article  PubMed  Google Scholar 

  • Lo Curto M, Lumia F et al (2003) Malignant germ cell tumors in childhood: results of the first Italian cooperative study “TCG 91”. Med Pediatr Oncol 41(5):417–425

    Article  PubMed  Google Scholar 

  • Lopes LF, Macedo CR et al (2009) Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. J Clin Oncol 27(8):1297–1303

    Article  PubMed  CAS  Google Scholar 

  • Mann JR, Raafat F et al (2000) The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18(22):3809–3818

    PubMed  CAS  Google Scholar 

  • Ortega JA, Douglass EC et al (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18(14):2665–2675

    PubMed  CAS  Google Scholar 

  • Pappo AS (2003) Melanoma in children and adolescents. Eur J Cancer 39(18):2651–2661

    Article  PubMed  CAS  Google Scholar 

  • Pastore G, De Salvo GL et al (2009) Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: the TREP project. Pediatr Blood Cancer 53(2):152–155

    Article  PubMed  Google Scholar 

  • Perilongo G, Shafford E et al (2004) Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology–SIOPEL 2. Eur J Cancer 40(3):411–421

    Article  PubMed  CAS  Google Scholar 

  • Perilongo G, Maibach R et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361(17):1662–1670

    Article  PubMed  CAS  Google Scholar 

  • Ries LA, Smith MAS, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) (1999) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program, NIH Publication No. 99–4649. National Cancer Institute, Bethesda

    Google Scholar 

  • Saab R, Furman WL (2008) Epidemiology and management options for colorectal cancer in children. Paediatr Drugs 10(3):177–192

    Article  PubMed  Google Scholar 

  • Schneider DT, Calaminus G et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42(2):169–175

    Article  PubMed  Google Scholar 

  • Smith MA, Seibel NL et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625–2634

    Article  PubMed  Google Scholar 

  • Strouse JJ, Fears TR et al (2005) Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 23(21):4735–4741

    Article  PubMed  Google Scholar 

  • Sultan I, Rodriguez-Galindo C et al (2010) Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer 116(3):758–765

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dominik T. Schneider .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Olson, T.A., Schneider, D.T., Brecht, I.B., Ferrari, A. (2012). Rare Tumors: A Different Perspective on Oncology. In: Schneider, D., Brecht, I., Olson, T., Ferrari, A. (eds) Rare Tumors In Children and Adolescents. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04197-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04197-6_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04196-9

  • Online ISBN: 978-3-642-04197-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics